Previous research indicated that NEURL1B was low expressed in colon cancer, and its low expression predicted a shorter survival time, suggesting that NEURL1B, as a tumor suppressor gene, participated in the pathological processes of colon cancer and may be served as potential biomarkers for early diagnosis and prognostic evaluation.25 This evidence concerns the gene NEURL1B and malignant colon neoplasm.